NMPA Actair coverage for business development, investment, and market access teams
Nuance Pharma has received IND clearance for its pivotal clinical trial of Actair® in China, a significant step in oncology development. This announcement has important implications for investors and business development teams.
We use cookies to enhance your experience, analyze traffic, and for marketing. By continuing to use our site, you consent to our use of cookies. Privacy Policy
